Theriva Biologics, Inc. (TOVX)
0.196
+0.01
(+3.16%)
USD |
NYAM |
Oct 23, 16:00
0.1916
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Market Cap : 8.995M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.995M |
| October 22, 2026 | 8.720M |
| October 21, 2026 | 9.022M |
| October 20, 2026 | 9.546M |
| October 19, 2026 | 9.394M |
| October 16, 2026 | 9.541M |
| October 15, 2026 | 9.729M |
| October 14, 2026 | 9.633M |
| October 13, 2026 | 9.899M |
| October 12, 2026 | 10.07M |
| October 09, 2026 | 9.959M |
| October 08, 2026 | 10.42M |
| October 07, 2026 | 10.74M |
| October 06, 2026 | 10.19M |
| October 05, 2026 | 10.33M |
| October 02, 2026 | 10.33M |
| October 01, 2026 | 10.33M |
| September 30, 2026 | 10.33M |
| September 29, 2026 | 9.638M |
| September 28, 2026 | 9.936M |
| September 25, 2026 | 10.12M |
| September 24, 2026 | 10.58M |
| September 23, 2026 | 10.77M |
| September 22, 2026 | 10.59M |
| September 21, 2026 | 10.59M |
| Date | Value |
|---|---|
| September 18, 2026 | 10.72M |
| September 17, 2026 | 11.11M |
| September 16, 2026 | 10.37M |
| September 15, 2026 | 10.33M |
| September 14, 2026 | 10.81M |
| September 11, 2026 | 11.36M |
| September 10, 2026 | 11.14M |
| September 09, 2026 | 11.43M |
| September 08, 2026 | 11.34M |
| September 04, 2026 | 11.61M |
| September 03, 2026 | 11.61M |
| September 02, 2026 | 11.39M |
| September 01, 2026 | 11.43M |
| August 31, 2026 | 11.47M |
| August 28, 2026 | 11.25M |
| August 27, 2026 | 11.59M |
| August 26, 2026 | 11.16M |
| August 25, 2026 | 10.90M |
| August 24, 2026 | 10.79M |
| August 21, 2026 | 10.78M |
| August 20, 2026 | 10.56M |
| August 19, 2026 | 10.34M |
| August 18, 2026 | 10.35M |
| August 17, 2026 | 10.90M |
| August 14, 2026 | 10.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| PS Ratio | 21.61 |
| Price to Book Value | 0.7381 |
| Price | 0.196 |
| Earnings Yield | -341.2% |